Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$8.76 USD
+0.25 (2.94%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $8.74 -0.02 (-0.23%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
TBPH 8.76 +0.25(2.94%)
Will TBPH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TBPH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TBPH
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Here's Why You May Invest in Theravance (TBPH) Stock Now
TBPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Predict a 90.53% Upside in Theravance Bio (TBPH): Here's What You Should Know
Theravance Bio (TBPH) Down 6.1% Since Last Earnings Report: Can It Rebound?
Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
Other News for TBPH
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Sidoti Events, LLC's Virtual June Small-Cap Conference
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Theravance Biopharma (TBPH) and Merus (MRUS)
Theravance Biopharma (TBPH) Receives a Hold from TD Cowen
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Theravance Biopharma (TBPH)